London, 2 July | Sunday 1 July 2012 9:14 pm EDT
London, July 2 (Reuters)-Financial Times headlines AGIUS to exit on LIBOR Coalition scandal puts HEATHROW decision on ice rating agencies face gilt auctions probe to be put ON HOLD for Olympics reviews VODAFONE MCLAREN F1 sponsorship automotive clash on European emissions L & G to offer SOCIAL HOUSING loans ASTRAZENECA eyes more deals after AMYLIN
Overview AGIUS to exit on LIBOR scandal Marcus Agius will resign as President of Barclays on Monday in the hope that his departure will take the sting out of criticism from politicians and shareholders to mounting on the Bank's role in fixing of interbank lending rates.
COALITION puts HEATHROW decision on the ice that the ruling coalition is planning to delay a decision on increasing airport capacity in the South East of England until after the next general election.
Credit rating agencies face probe The European markets watchdog is investigating whether the methods of credit rating agencies evaluating the three major banks are quite transparent and rigorous, its President Steven Maijoor said in an interview.
GILT auctions to be put ON HOLD for the Olympics the United Kingdom Treasury has called off its weekly gilt auctions for a period of four weeks between mid-July and mid-August, apparently because it fears that too many bond traders will be working from home-or at all-as Vodafone Olympics. VODAFONE reviews MCLAREN F1 sponsorship is reviewing its global sports and sponsorship of events including title sponsorship of McLaren Formula 1.
European carmakers ' row ON emissions fight has erupted between manufacturers of premium of Germany and their French and Italian competitors over the formula used by the European Commission to grant long-term objectives of CO2-cutting producers.
L & G to offer SOCIAL HOUSING loans insurance legal General & is to start providing loans to housing associations, the latest example of a new lender moving to exploit the lack of bank finance for real estate.
ASTRAZENECA eyes more deals after AMYLIN AstraZeneca has money and appetite for more acquisitions, the acting head of the Anglo-Swedish pharmaceutical group said after his purchase innovative joint $ 7 billions of Amylin with Bristol-Myers Squibb over the weekend finalising.
0 comments:
Post a Comment